Life span and locomotor activity modification by glucose and polyphenols in Drosophila melanogaster chronically exposed to oxidative stress-stimuli: Implications in Parkinson's disease

Neurochemical Research

Volumn 36, Issue 6, 2011, Pages 1073-1086

  Ortega Arellano, Hector Flavio ^a   Jimenez Del Rio, Marlene ^a   Velez Pardo, Carlos ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Drosophila; Glucose; Iron; Locomotor; Paraquat; Parkinson; Polyphenol

Indexed keywords

EPICATECHIN; EPIGALLOCATECHIN GALLATE; GALLIC ACID; GALLIC ACID PROPYL ESTER; GLUCOSE; IRON; PARAQUAT; POLYPHENOL DERIVATIVE; TRANSCRIPTION FACTOR GAL4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; DRUG EFFICACY; DRUG SCREENING; FEMALE; LIFE EXTENSION; LOCOMOTION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; SURVIVAL RATE; TRANSGENIC ORGANISM;

ANIMALS; DROSOPHILA MELANOGASTER; GLUCOSE; LOCOMOTION; LONGEVITY; OXIDATIVE STRESS; PARKINSON DISEASE;

DROSOPHILA MELANOGASTER;

EID: 79955695012     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-011-0451-0     Document Type: Article

References (50)

1. Jankovic J (2008) Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79(4):368-376
2. Forno LS (1996) Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 55:259-272
3. Cuervo AM, Wong ES, Martinez-Vicente M (2010) Protein degradation, aggregation, and misfolding. Mov Disord 25(Suppl 1):S49-S54
4. Sian-Hülsmann J, Mandel S, Youdim HMB, Riederer P (2010) The relevance of iron in the pathogenesis of Parkinson's disease. J Neurochem. doi:10.1111/j.1471-4159.2010.07132.x
5. Cookson MR (2010) Unravelling the role of defective genes. Prog Brain Res 183:43-57
6. Jankovic J, Aguilar LG (2008) Current approaches to the treatment of Parkinson's disease. Neuropsychiatr Dis Treat 4(4):743-757
7. Zhou C, Huang Y, Przedborski S (2008) Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance. Ann N Y Acad Sci 1147:93-104
8. Xie W, Wan OW, Chung KK (2010) New insights into the role of mitochondrial dysfunction and protein aggregation in Parkinson's disease. Biochim Biophys Acta 1802(11):935-941
9. Chen H, O'Reilly E, McCullough ML, Rodriguez C, Schwarzschild MA, Calle EE, Thun MJ, Ascherio A (2007) Consumption of dairy products and risk of Parkinson's disease. Am J Epidemiol 165(9):998-1006
10. Dick FD, De Palma G, Ahmadi A, Scott NW, Prescott GJ, Bennett J, Semple S, Dick S, Counsell C, Mozzoni P, Haites N, Wettinger SB, Mutti A, Otelea M, Seaton A, Soderkvist P, Felice A; Geoparkinson Study Group (2007) Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study. Occup Environ Med 64:666-672 (Pubitemid 47488093)
11. Jones DC, Miller GW (2008) The effects of environmental neurotoxicants on the dopaminergic system: a possible role in drug addiction. Biochem Pharmacol 76:569-581
12. Logroscino G, Gao X, Chen H, Wing A, Ascherio A (2008) Dietary iron intake and risk of Parkinson's disease. Am J Epidemiol 168(12):1381-1388
13. Hirth F (2010) Drosophila melanogaster in the study of human neurodegeneration. CNS Neurol Disord Drug Targets 9(4): 504-523
14. Botella JA, Bayersdorfer F, Gmeiner F, Schneuwly S (2009) Modelling Parkinson's disease in Drosophila. Neuromolecular Med 11(4):268-280
15. Park J, Kim Y, Chung J (2009) Mitochondrial dysfunction and Parkinson's disease genes: insights from Drosophila. Dis Model Mech 2(7-8):336-340
16. Bayersdorfer F, Voigt A, Schneuwly S, Botella JA (2010) Dopamine-dependent neurodegeneration in Drosophila models of familial and sporadic Parkinson's disease. Neurobiol Dis 40(1):113-119
17. Phelps CB, Brand AH (1998) Ectopic gene expression in Drosophila using GAL4 system. Methods 14(4):367-379
18. Feany MB, Bender WW (2000) A Drosophila model of Parkinson's disease. Nature 404:394-398 (Pubitemid 30164341)
19. Mao Z, Davis RL (2009) Eight different types of dopaminergic neurons innervate the Drosophila mushroom body neuropil: anatomical and physiological heterogeneity. Front Neural Circuits 3:5
20. White KE, Humphrey DM, Hirth F (2010) The dopaminergic system in the aging brain of Drosophila. Front Neurosci 4:205
21. Riemensperger T, Isabel G, Coulom H, Neuser K, Seugnet L, Kume K, Iché-Torres M, Cassar M, Strauss R, Preat T, Hirsh J, Birman S (2011) Behavioral consequences of dopamine deficiency in the Drosophila central nervous system. Proc Natl Acad Sci USA 108(2):834-839
22. Faust K, Gehrke S, Yang Y, Yang L, Beal MF, Lu B (2009) Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease. BMC Neurosci 10:109
23. Pendleton RG, Rasheed A, Sardina T, Tully T, Hillman R (2002) Effects of tyrosine hydroxylase mutants on locomotor activity in Drosophila: a study in functional genomics. Behav Genet 32:89-94 (Pubitemid 34522416)
24. Wang C, Lu R, Ouyang X, Ho MW, Chia W, Yu F, Lim KL (2007) Drosophila overexpressing parkin R275 W mutant exhibits dopaminergic neuron degeneration and mitochondrial abnormalities. J Neurosci 27:8563-8570 (Pubitemid 47254271)
25. Sang TK, Chang HY, Lawless GM, Ratnaparkhi A, Mee L, Ackerson LC, Maidment NT, Krantz DE, Jackson GR (2007) A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine. J Neurosci 27:981-992 (Pubitemid 46203305)
26. Pendleton RG, Parvez F, Sayed M, Hillman R (2002) Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster. J Pharmacol Exp Ther 300:91-96 (Pubitemid 34028513)
27. Coulom H, Birman S (2004) Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster. J Neurosci 24:10993-10998 (Pubitemid 39602410)
28. Chaudhuri A, Bowling K, Funderburk C, Lawal H, Inamdar A, Wang Z, O'Donnell JM (2007) Interaction of genetic and environmental factors in a Drosophila parkinsonism model. J Neurosci 27:2457-2467 (Pubitemid 46393605)
29. Cocheme HM, Murphy MP (2008) Complex I is the major site of mitochondrial superoxide production by paraquat. J Biol Chem 283:1786-1798
30. Bonilla E, Medina-Leendertz S, Villalobos V, Molero L, Bohórquez A (2006) Paraquat-induced oxidative stress in drosophila melanogaster: effects of melatonin, glutathione, serotonin, minocycline, lipoic acid and ascorbic acid. Neurochem Res 31(12):1425-1432 (Pubitemid 44900582)
31. Jimenez-Del-Rio M, Daza-Restrepo A, Velez-Pardo C (2008) The cannabinoid CP55, 940 prolongs survival and improves locomotor activity in Drosophila melanogaster against paraquat: implications in Parkinson's disease. Neurosci Res 61:404-411
32. Jimenez-Del-Rio M, Guzman-Martinez C, Velez-Pardo C (2010) The effects of polyphenols on survival and locomotor activity in Drosophila melanogaster exposed to iron and paraquat. Neurochem Res 35(2):227-238
33. Savica R, Rocca WA, Ahlskog JE (2010) When does Parkinson disease start? Arch Neurol 67(7):798-801
34. Tan JM, Wong ES, Lim KL (2009) Protein misfolding and aggregation in Parkinson's disease. Antioxid Redox Signal 11(9):2119-2134
35. Haywood AFM, Saunders LD, Staveley BE (2002) Dopa decarboxylase (Ddc)-GAL4 dramatically reduces life span. Dros Inf Serv 85:42-45
36. Pineda-Trujillo N, Apergi M, Moreno S, Arias W, Lesage S, Franco A, Sepulveda-Falla D, Cano D, Buritica O, Pineda D, Uribe CS, de Yebenes JG, Lees AJ, Brice A, Bedoya G, Lopera F, Ruiz-Linares A (2006) A genetic cluster of early onset Parkinson's disease in a Colombian population. Am J Med Genet B Neuropsychiatr Genet 141B(8):885-888
37. Perron NR, Brumaghim JL (2009) A review of the antioxidant mechanisms of polyphenol compounds related to iron binding. Cell Biochem Biophys 53(2):75-100
38. Maher P (2005) The effects of stress and aging on glutathione metabolism. Ageing Res Rev 4(2):288-314
39. Borghammer P, Chakravarty M, Jonsdottir KY, Sato N, Matsuda H, Ito K, Arahata Y, Kato T, Gjedde A (2010) Cortical hypometabolism and hypoperfusion in Parkinson's disease is extensive: probably even at early disease stages. Brain Struct Funct 214(4):303-317
40. Miyake Y, Tanaka K, Fukushima W, Sasaki S, Kiyohara C, Tsuboi Y, Yamada T, Oeda T, Miki T, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M, the Fukuoka Kinki Parkinson's Disease Study Group (2010) Lack of association of dairy food, calcium, and vitamin D intake with the risk of Parkinson's disease: a case-control study in Japan. Parkinsonism Relat Disord (in press)
41. Jimenez-Del-Rio M, Velez-Pardo C (2008) Paraquat induces apoptosis in human lymphocytes: protective and rescue effects of glucose, cannabinoids and Insulin-like growth factor-1. Growth Factors 26(1):49-60
42. Jimenez Del Rio M, Velez-Pardo C (2004) Transition metals-induced apoptosis in lymphocytes via hydroxyl radical generation, mitochondria dysfunction and caspase-3 activation: an in vitro model for neurodegeneration. Arch Med Res 35:185-193 (Pubitemid 38648986)
43. Rezával C, Werbajh S, Ceriani MF (2007) Neuronal death in Drosophila triggered by GAL4 accumulation. Eur J Neurosci 25:683-694 (Pubitemid 46277017)
44. Kramer JM, Staveley BE (2003) GAL4 causes developmental defects and apoptosis when expressed in the developing eye of Drosophila melanogaster. Genet Mol Res 2(1):43-47 (Pubitemid 38846548)
45. Perron NR, Brumaghim JL (2009) A review of the antioxidant mechanisms of polyphenol compounds related to iron binding. Cell Biochem Biophys 53:75-100
46. Li YM, Edwin Schan HY, Hunag Y, Chen ZY (2007) Green tea catechins upregulate superoxide dismutase and catalase. Mol Nutr Food Res 51:554-564
47. Soobrattee MA, Neergheen VS, Luximon-Ramma A, Aruoma OI, Bahorun T (2005) Phenolics as potential antioxidant therapeutic agents: mechanism and actions. Mutat Res 579(1-2):200-213 (Pubitemid 41540144)
48. D'Archivio M, Filesi C, Di Benedetto R, Gargiulo R, Giovannini C, Masella R (2007) Polyphenols, dietary sources and bioavailability. Ann Ist Super Sanita 43(4):348-361
49. D'Archivio M, Filesi C, Varì R, Scazzocchio B, Masella R (2010) Bioavailability of the polyphenols: status and controversies. Int J Mol Sci Mar 11(4):1321-1342
50. Surendran S, Rajasankar S (2010) Parkinson's disease: oxidative stress and therapeutic approaches. Neurol Sci 31(5):531-540